2023
DOI: 10.3390/jcdd10040148
|View full text |Cite
|
Sign up to set email alerts
|

Growing Heart Valve Implants for Children

Abstract: The current standard of care for pediatric patients with unrepairable congenital valvular disease is a heart valve implant. However, current heart valve implants are unable to accommodate the somatic growth of the recipient, preventing long-term clinical success in these patients. Therefore, there is an urgent need for a growing heart valve implant for children. This article reviews recent studies investigating tissue-engineered heart valves and partial heart transplantation as potential growing heart valve im… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
8
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 65 publications
0
8
0
Order By: Relevance
“…A pHT is a potential procedure that is of interest to treat congenital heart diseases involving the recovery and transplantation of a donor heart valve [8]. Typically, congenital heart diseases require either a full, deceased donor heart transplant, or a valve replacement with either a mechanical valve or a bioprosthetic cadaveric tissue valve homograft.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…A pHT is a potential procedure that is of interest to treat congenital heart diseases involving the recovery and transplantation of a donor heart valve [8]. Typically, congenital heart diseases require either a full, deceased donor heart transplant, or a valve replacement with either a mechanical valve or a bioprosthetic cadaveric tissue valve homograft.…”
Section: Discussionmentioning
confidence: 99%
“…In this ambiguous milieu, and with the recent introduction of a partial heart transplantation (pHT), it is of value to discuss the mechanism of CIT and WIT and how it may influence outcomes for a pHT. This paper aims to discuss the physiological basis of cellular damage due to CIT, CIT variation among different organs, and how CIT/WIT may play an important role in the value of a pHT and procurement of heart valves [8].…”
Section: Introductionmentioning
confidence: 99%
“…Despite an intensive research effort involving myriad cell types, scaffolds and strategies for cellularizing the scaffolds, all tissue engineering approaches to develop growing heart valve implants have failed in clinical translation. 17,19,20,21,22,23 Similar issues have plagued other applications for tissue engineering, such as attempts to create an artificial trachea. 24,25 This has resulted in some of the biggest biomedical research scandals of our time, including the Paolo Macchiarini scandal.…”
Section: Tissue-engineered Heart Valve Implantsmentioning
confidence: 99%
“…16 Growing heart valve implants would improve morbidity and mortality by avoiding the need to attempt complex valve repairs and by decreasing future reinterventions. 17…”
mentioning
confidence: 99%
“…Bioprosthetic heart valves can overcome some of the limitations of mechanical heart valves, but their durability is limited to 10–15 years, making them unsuitable for younger patients [ 4 , 5 ]. In pediatric patients, both types of valve prostheses require frequent resizing surgeries due to their inability to remodel and adapt to growth [ 6 ].…”
Section: Introductionmentioning
confidence: 99%